MORF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.83350001847771E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.5609000000012E-05 |
Normal-vs-Stage2 |
4.01930000004658E-06 |
Normal-vs-Stage3 |
7.1098682496995E-13 |
Normal-vs-Stage4 |
1.21840004752016E-09 |
Stage1-vs-Stage2 |
1.344780E-01 |
Stage1-vs-Stage3 |
2.57079999999021E-06 |
Stage1-vs-Stage4 |
1.317220E-03 |
Stage2-vs-Stage3 |
4.262000E-02 |
Stage2-vs-Stage4 |
2.140400E-01 |
Stage3-vs-Stage4 |
4.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.1021999979377E-09 |
Normal-vs-AfricanAmerican |
1.859920E-02 |
Normal-vs-Asian |
1.737610E-03 |
Caucasian-vs-AfricanAmerican |
6.644000E-01 |
Caucasian-vs-Asian |
3.810800E-01 |
AfricanAmerican-vs-Asian |
2.659400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.90150000189959E-08 |
Normal-vs-Female |
1.28560051493309E-10 |
Male-vs-Female |
4.907800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.375200E-03 |
Normal-vs-Age(41-60Yrs) |
2.76809997146188E-09 |
Normal-vs-Age(61-80Yrs) |
1.42440000017174E-07 |
Normal-vs-Age(81-100Yrs) |
6.32790000000272E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.698200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.079600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.817600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.724400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.640200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.779200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.746200E-01 |
Normal-vs-Grade 2 |
5.99629999999962E-05 |
Normal-vs-Grade 3 |
4.05519950952282E-10 |
Normal-vs-Grade 4 |
4.43880487921433E-11 |
Grade 1-vs-Grade 2 |
3.173400E-01 |
Grade 1-vs-Grade 3 |
5.443000E-03 |
Grade 1-vs-Grade 4 |
3.599300E-03 |
Grade 2-vs-Grade 3 |
3.297700E-03 |
Grade 2-vs-Grade 4 |
2.996300E-04 |
Grade 3-vs-Grade 4 |
2.087200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.304960E-03 |
Normal-vs-ccB subtype |
4.53648230092085E-12 |
ccA subtype-vs-ccB subtype |
1.63523999999748E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.35490000330307E-08 |
Normal-vs-N1 |
9.08089999973605E-07 |
N0-vs-N1 |
1.083800E-01 |
|
|